← SynDRA
NGP 555
SynDRA canonical compound SYN1959568 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | APH1A | APH1B |
|---|
| Mechanism of action | gamma secretase modulator |
|---|
All known targets
- APH1A
- APH1A; APH1B; NCSTN; PSENEN; PSEN1
- APH1B
Mechanisms of action (all sources)
- gamma secretase modulator
- Modulator
Cross-references
Synonyms
- WDEKUGNKKOGFOA-UHFFFAOYSA-N
- NGP555
- UNII-1XA7T7L527
- CHEMBL2151100
- SCHEMBL16198584
- NGP-455
- 1XA7T7L527
- HY-108714
- CS-0030521
- 2-Thiazolamine, N-(5-ethyl-2,4-dimethylphenyl)-4-(3-fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl)-
- N-(5-Ethyl-2,4-dimethylphenyl)-4-(3-fluoro-4-(4-methylimidazol-1-yl)phenyl)-1,3-thiazol-2-amine
Look up NGP 555 in the interactive SynDRA portal →